Data protection legislation: interpretation and barriers to research

Affiliations

J Strobl et al. BMJ. 2000.

. 2000 Oct 7;321(7265):890-2.

doi: 10.1136/bmj.321.7265.890.

¹ Prescribing Research Group, Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool L69 3GE. strobl@liv.ac.uk

No abstract available

Comment in

Data protection and patients' consent. GMC is greater threat to research than the act.
Ellis SJ. Ellis SJ. BMJ. 2001 Mar 3;322(7285):550. BMJ. 2001. PMID: 11230075 No abstract available.
Data protection and patients' consent. New Zealand model of consent offers solution.
Dovey S, Tilyard M. Dovey S, et al. BMJ. 2001 Mar 3;322(7285):550. BMJ. 2001. PMID: 11230077 No abstract available.
GMC's guidance may inhibit research.
Leslie SJ, Webb DJ. Leslie SJ, et al. BMJ. 2001 Jun 30;322(7302):1601-2. BMJ. 2001. PMID: 11458899 Free PMC article. No abstract available.

1. Department of Health. Research and development: towards an evidence-base for health services, public health and social care. London: DoH; 1998. www.doh.gov.uk/pub/docs/doh/rdd1.pdf . (Information pack available at www.doh.gov.uk/pub/docs/doh/rdd1.pdf.) .)
1. Directive 95/46/EC of the European Parliament and of the Council of 24 October 1995 on the protection of individuals with regard to the processing of personal data and on the free movement of such data. Official Journal of the European Communities No L 1995 Nov 23;38:31-55. www2.echo.lu/legal/en/dataprot/directiv/directiv.html (accessed 19 November 1999).
1. NHS Executive. Protecting and using patient information—a manual for Caldicott guardians. Leeds: NHS Executive; 1999. www.doh.gov.uk/confiden/cgmsum.htm (accessed 19 November 1999).
1. Caldicott Committee. Report on the review of patient-identifiable information. London: Department of Health; 1997.
1. NHS Executive. Caldicott guardians. Leeds: NHS Executive; 1999. . (HSC 1999/012)